tebu-bio is a European company specialised in providing innovative reagents and laboratory services in Life Sciences
X

Need an answer now?

Give us a call

Leave a message, we'll get back to you





Cost-effective, healthy growth & undifferentiation of ES/iPS cells

Traditionally, fetal bovine serum (FBS) has been used as an additive to cell culture media for the in vitro growth of pluripotent stem cells. Fetal bovine serum is an inherently variable component of the cell culture system so consistent performance demands extensive screening of manufactured lots. To circumvent this problem, companies began offering “stem cell qualified” serum. One issue with this solution is that the qualification is not always performed on a stem cell line relevant to the researchers own cell lines. Years later, research began using Life Technologies Knockout® Serum Replacement (KOSR) to grow and maintain undifferentiated human embryonic stem cells in culture. While KOSR has shown to be more stable than FBS and performs better in maintaining undifferentiated embryonic stem (ES) and induced pluripotent stem (iPS) cells, it is expensive. 

Many researchers today are looking for a more cost effective media solution for their pluripotent stem cell culture. To address this need within the scientific community, GlobalStem has developed a more economical solution with their new PluriQ™ Serum Replacement (QSR).

PluriQ™ Serum Replacement - same high quality, lower price...

This defined, cost-effective serum replacer maximally supports undifferentiated Human pluripotent stem cell growth in feeder-based cell culture systems.

Extensive validation data has shown that human embryonic stem cells cultured for 20 passages in QSR supports healthy growth and proliferation of cells while also maintaining them in their undifferentiated and karyotypically normal state.

Browse PluriQ products

Results to prove equal efficiency

Healthy, Undifferentiated Colony Morphology

Figure 1.  Human ES cells cultured in PluriQ™ SR show normal, healthy colonies though 20 passages. Above images show representative colonies from passage 6 (A) , passage 14 (B), and passage 20 (C).

Supports Stem Cell Growth, Maintains Pluripotency

Figure 2. Oct4 Staining. Human ES cells cultured in PluriQ™ SR maintain pluripotency over extended passages. Images (left) show representative cell colonies stained with anti Oct4 after 11 passages.

Figure 3. Pluripotency Markers. Flow Cytometry analysis of human ES cells co‐cultured in PluriQ™ SR for 20 passages show high expression of Oct‐4 (left), SSEA4 (center), and TRA‐1‐81 (right).

Maintains Normal Karyotype after 20 Passages

Figure 4. - Human ESC grown in 20% GlobalStem QSR on a MEF feeder layer for 20 passages were assayed periodically for the level of the undifferentiated state by testing samples with GlobalStem PluriPCR™ Kit. The graph on the left shows cells tested at P0, P10, P16 and P20. Note that while there was a slight initial decrease in the expression of the markers, the cells recovered while still in culture. The plot on the right shows that after 20 passages in QSR, the cells retain their ability to form embryoid bodies (EB) and undergo spontaneous differentiation. EB formation and differentiation was performed in 20% QSR.

Note the marked decrease in expression of the undifferentiated markers from T0 (P20) to T1 (1 week) to T2 (2 week) of EB formation. Samples were always run together with a positive control – RNA extracted from the human teratocarcinoma cell line 2102Ep (CAL RNA, GlobalStem GSC-2001) – and a negative control – RNA extracted from human fibroblasts (FIB RNA, GloblalStem GSC-3002).

Figure 5. - (A) Immunophenotyping using flow cytometry of the hESC after 20 passages in QSR supports the results obtained with qPCR. Note the high levels of expression of the three undifferentiated markers tested. (B) G-Banding cell counts of hESC after 10 and 20 passages in culture with 20% QSR, shown together with a full karyotype of one cell at P20. Note the karyotypic stability of the hESC line in QSR supplement.